Lates News

AstraZeneca: Ceralasertib can be used to treat advanced non-small cell lung cancer. The overall tolerability of the combination therapy of Ceralasertib and Imfinzi is good. The safety profile is consistent with what is known for each drug, and no new safety concerns have been identified.